Stem Cells and Myocardial Regeneration

E. Michael Molnar

doi:10.29333/ejgm/82238

Full Text (PDF)

E. Michael Molnar ¹ ^*

More Detail

¹ Bio-Cellular Research Organization, Barksdale Professional Center, Newark, DE, USA^* Corresponding Author

Abstract

Cardiomyocytes lose their ability to proliferate after birth and so heart muscle fibers cannot regenerate. For that reason myocardial injury, such as myocardial infarction (MI), heals by replacement of contractile heart muscle fibers by fibrotic tissue scar, which not only cannot participate in pumping of blood, it does not even contribute to passive mechanics of heart. Massive loss of cardiomyocytes after MI is a common cause of heart failure (HF), which is a consequence of many other cardiovascular diseases, and serious public health problem.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Review Article

EUR J GEN MED, Volume 1, Issue 4, October 2004, 7-14

https://doi.org/10.29333/ejgm/82238

Publication date: 15 Oct 2004

Article Views: 1224

Article Downloads: 736

Open Access References How to cite this article

References

Menasche P, Hagege A, Scorsin M, et al. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss 2001;94:180-2
Strauer BE, Brehm M, Zeus T, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 2001: 126:932-8
Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation. Circulation 2002; 106:1913-6
Suzuki K, Murtuza B, Heslop L, et al. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg 2002;123:984- 92
Pouzet B, Ghostine S, Vilquin JT, et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors, Circulation 2001;104 (Suppl 1):1223-8
Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001;103:1920-7
Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engrafment and functional effect. Ann Thorac Surg 2002;73:1919-25
Li RK, Jia ZQ, Weisel RD, Marante F, Mickle DA. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999;31:513-22
Min YI, Yang Y, Converso KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002;92:288-96
Malouf NN, Coleman WB, Grisham JW, et al. Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol 2001;158:1929-35
Matsushita T, Oyamada M, Kurata H, et al. Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation 1999;19 (Suppl II):262-8
Ruhparwar A, Tebbeenjohans J, Niehaus M, et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg 2002;21:853-7
Scorsin M, Hagege A, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocytes and skeletal myoblasts transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000;119:1169-75
Sakai T, Li RK, Weisel RD, et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 1999;118:714-24
Hutcheson KA, Atkins BZ, Hueman MT, et al. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts Cell Transplant 2000;9:359-68
Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957-63
Roell W, Lu ZJ, Bloch W, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105: 2435-41
Muller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: longterm survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002;105:1720-26
Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immunotolerance of adult stem cells. Ann Thorac Surg 2002;74:19-24
Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8
Etzion S, Battler A, Barbash IM, et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001;33:1321-30
Kim EJ, Li RK, Weizel RD, et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001;122:963-71
Dornbusch S. The effect of placenta on experimental cholesterinsclerosis. In Schmid F, Stein J. Cell-research and Cellular therapie (Ott Publishers. Thun, Switzerland, 1967), 134-40
Cunningham FG, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Williams Obstetrics. 19th ed (Appleton&Lange, 1993)
Schmid F, Stein J. Cell-research and Cellular therapie (Ott Publishers, Thun, Switzerland, 1967)
Schmid F, Stein J. Zellforschung und Zelltherapie (Verlag H. Huber, Bern, Stuttgart, 1963)
Oetzmann HJ. Cell therapy for diseases of organs. In Schmid F, Stein J, Cell-research and Cellular therapie (Ott Publishers. Thun, Switzerland, 1967), 149-85
Schmid F. Zelltherapie-GrundlagenKlinik-Praxis (Ott-Verlag, Thun, Switzerland, 1981)
Schmid F. Cell therapy, a New Dimension of Medicine (Ott Publishers, Thun, Switzerland, 1983)
Hendricks PJ, Martens A, Hagenbeek A, et al. Homing of fluorescently labaled murine hematopoietic stem cells. Exp Hematol 1996; 24:129-40
Zanjani E, Ascensao J, Tavassoli M. Liver-derived hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 1993;81:399- 404
Hardy C. The homing of hematopoietic stem cells to the bone marrow. Am J Med Sci 1995; 309:260-6
Gilbert SF. Developmental Biology, 4th ed (Sinauer Associates, Sunderland MA, 1994)
Lenmark A, Freedman ZR, Hofmann C. Islet-cell-surface antibodies in juvenile diabetes mellitus, N Eng J Med 1978;299: 375-80
Kondrat’ev YaYu, Sadovnikova NV, Liozner AL, Fedotov VP. Antibodies to the surface of pancreatic islet cells: immunoenzymatic determination with rat target cells. Problemi Endokrinologii 1986;32:39-43
Hopf U, Meyer zum Buschenfelde KH, Freudenberg J. Liver-specific antigens of different species. Clin Exp Immunol 1974; 16:117-24
Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular Cell Biology, 3rd ed (Scientific American Books, New York, 1995)

How to cite this article

Vancouver

Molnar EM. Stem Cells and Myocardial Regeneration. EUR J GEN MED. 2004;1(4):7-14. https://doi.org/10.29333/ejgm/82238

APA

Molnar, E. M. (2004). Stem Cells and Myocardial Regeneration. European Journal of General Medicine, 1(4), 7-14. https://doi.org/10.29333/ejgm/82238

AMA

Molnar EM. Stem Cells and Myocardial Regeneration. EUR J GEN MED. 2004;1(4), 7-14. https://doi.org/10.29333/ejgm/82238

Chicago

Molnar, E. Michael. "Stem Cells and Myocardial Regeneration". European Journal of General Medicine 2004 1 no. 4 (2004): 7-14. https://doi.org/10.29333/ejgm/82238

Harvard

Molnar, E. M. (2004). Stem Cells and Myocardial Regeneration. European Journal of General Medicine, 1(4), pp. 7-14. https://doi.org/10.29333/ejgm/82238

MLA

Molnar, E. Michael "Stem Cells and Myocardial Regeneration". European Journal of General Medicine, vol. 1, no. 4, 2004, pp. 7-14. https://doi.org/10.29333/ejgm/82238

Electronic Journal of General Medicine

Abstract

License